Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1988-11-21
1992-04-14
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424520, 424530, 424531, 424545, 424570, 73 611C, 436 63, 436150, 436161, 2041531, 514 1, G01N 100, G01N 3348, G01N 2508, A61K 3100
Patent
active
051046393
ABSTRACT:
A method for establishing a treatment protocol for correcting an abnormal condition or disease in a living organism is described. The method comprises the steps of analyzing body fluids from normal and abnormal individuals to generate analysis patterns of the normal and abnormal fluids, comparing the patterns to determine differences in the patterns, and establishing a treatment protocol for the abnormal individual through chemical or metabolic therapy which treating will normalize the abnormal pattern.
REFERENCES:
patent: 4046634 (1977-09-01), Mercer
patent: 4215109 (1980-07-01), Rohenstroth-Bauer
patent: 4233031 (1980-11-01), Matson et al.
patent: 4338811 (1982-07-01), Miyagi et al.
patent: 4404065 (1983-09-01), Matson
patent: 4511659 (1985-04-01), Matson
patent: 4863873 (1989-09-01), Matson
Guy, Michael N. et al., Analysis of Angiotensins I, II III and Iodinated Derivatives by High Performance Liquid Chromatrography, Analytical Biochem., 112: 272-7 (1981).
Okwusaba, F. et al., Changes in Vasoactive Properties of Blood Products with Time and Attempted Identification of the Spasmogens, Stroke 12(6): 775-80 (1981).
Clin. Chem 30/9, pp. 1477-1488 (1984) Matson et al., "n-Electrode Three-Dimensional Liquid Chromatography with Electrochemical Detection for Determination of Neurotransmitters".
Journal of Liquid Chromatography, 6(2), pp. 375-381 (1983) Yamaguchi "Liquid Chromatographic Determination of Excretion Patterns of Urinary Phenolic Compounds".
Biological Markers in Psychiatry and Neurology, Proc. of a conference at Ochsner Clinic, New Orleans (1982), Schildkraut, "Biochemical Discrimination of Subgroups of Depressive Disorders Based on Differences in Catecholamine Metabolism" see pp. 23-33.
La Nouvelle Presse Medicalle, 9, pp. 2061-2063 (1980) Devynck et al., "Dosage rapide des Catecholamines Plasmatiques Pour le Diagnostic d'urgence des Pheochromocytomes".
Journal of Clinical Endocrinology and Metabolism, 50(5), pp. 857-861 (1980), Gullner et al., "Correction of Increased Sympathoadrenal Activity in Bartter's Syndrome by Inhibition of Prostaglandin Synthesis".
Archives of General psychiatry, 35, pp. 1427-1433 (1978) Schildkraut et al., "Toward a Biochemical Classification of Depressive Disorders".
British Medical Journal (1969) 2, 153-155, Marks et al., "Application of Urine Analysis to Diagnosis and Treatment of Heroin Addiction".
Clinical Pharmacology and Therapeutics, 7(6), pp. 727-739 (1966) Anton et al., "The Effect of Resperine on Catecholamine Metabolism and Behavior in Retarded Children".
Psychopharmacology (n.Y.) pp. 275-328 (1976) Schildkraut et al., "Biochemistry of Effective Disorders" CA85(25)190161d Abstract only.
Psychopharmacology (Berlin), 56(3), pp. 327-333, (1978) Schildkraut et al., "Opiates, Catecholanines, Behavior, and Mood" 89:53498n Abstract only.
Journal of American Geriatr. Soc., 25(7), pp. 289-298 (1977) Meyer et al., "Neurotransmitter Precursor Amino Acids in the Treatment of Multi-Infarct Dementia and Alzheimer's Disease" Index Medicus Journal Announcement: 7709 Abstract only.
Esa Inc.
Hollinden Gary
Raymond Richard L.
LandOfFree
Method for biological testing and/or developing pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for biological testing and/or developing pharmaceuticals , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for biological testing and/or developing pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2347591